AHSP
Basic information
Region (hg38): 16:31527900-31528803
Previous symbols: [ "ERAF" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AHSP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 10 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 9 | 1 | 1 |
Variants in AHSP
This is a list of pathogenic ClinVar variants found in the AHSP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-31528171-T-C | not specified | Uncertain significance (Sep 10, 2024) | ||
16-31528200-C-T | Likely benign (Feb 01, 2023) | |||
16-31528211-G-C | not specified | Uncertain significance (Aug 08, 2024) | ||
16-31528470-C-T | not specified | Uncertain significance (Oct 01, 2024) | ||
16-31528476-G-C | not specified | Uncertain significance (Mar 29, 2023) | ||
16-31528510-A-G | not specified | Uncertain significance (Feb 20, 2025) | ||
16-31528518-A-G | not specified | Uncertain significance (Jan 19, 2024) | ||
16-31528520-C-T | AHSP-related disorder | Likely benign (Apr 09, 2019) | ||
16-31528573-A-G | not specified | Uncertain significance (Dec 07, 2021) | ||
16-31528606-A-T | AHSP-related disorder | Uncertain significance (Nov 06, 2023) | ||
16-31528613-G-T | AHSP-related disorder | Benign (Oct 23, 2019) | ||
16-31528635-T-C | not specified | Uncertain significance (Oct 03, 2024) | ||
16-31528642-A-T | not specified | Uncertain significance (Mar 21, 2023) | ||
16-31528680-C-A | Benign (Jun 21, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AHSP | protein_coding | protein_coding | ENST00000302312 | 2 | 940 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000329 | 0.218 | 125736 | 0 | 12 | 125748 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.248 | 59 | 53.9 | 1.10 | 0.00000290 | 668 |
Missense in Polyphen | 14 | 12.991 | 1.0777 | 188 | ||
Synonymous | -0.131 | 24 | 23.2 | 1.03 | 0.00000128 | 197 |
Loss of Function | -1.50 | 4 | 1.82 | 2.20 | 7.71e-8 | 23 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000703 | 0.0000703 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a chaperone to prevent the harmful aggregation of alpha-hemoglobin during normal erythroid cell development. Specifically protects free alpha-hemoglobin from precipitation. It is predicted to modulate pathological states of alpha-hemoglobin excess such as beta-thalassemia. {ECO:0000269|PubMed:12066189}.;
- Pathway
- hemoglobins chaperone
(Consensus)
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- loftool
- 0.700
- rvis_EVS
- 0.41
- rvis_percentile_EVS
- 76.67
Haploinsufficiency Scores
- pHI
- 0.309
- hipred
- N
- hipred_score
- 0.221
- ghis
- 0.432
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.731
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ahsp
- Phenotype
- immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cellular phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein folding;hemoglobin metabolic process;hemopoiesis;erythrocyte differentiation;protein stabilization
- Cellular component
- cytoplasm;hemoglobin complex
- Molecular function
- protein binding;hemoglobin binding;unfolded protein binding